US 12403164
Lentiviral vector formulations
granted A61KA61K35/76A61K47/26
Quick answer
US patent 12403164 (Lentiviral vector formulations) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/76, A61K47/26, A61P, A61P7/04